新发现的与肥胖症和2型糖尿病发病机制相关的脂肪因子。
New Discovered Adipokines Associated with the Pathogenesis of Obesity and Type 2 Diabetes.
作者信息
Cheng Jia-Xue, Yu Ke
机构信息
Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, People's Republic of China.
出版信息
Diabetes Metab Syndr Obes. 2022 Aug 7;15:2381-2389. doi: 10.2147/DMSO.S376163. eCollection 2022.
Abstract
Obesity is defined as abnormal or excessive accumulation of adipose tissue, closely associated with the increased risk of various comorbidities, especially type 2 diabetes mellitus (T2DM). Adipose tissue is a complex structure responsible for not only fat storage but also releasing adipokines which may play roles in the pathogenesis and could be developed into biomarkers for diagnosis, treatment and prognosis of obesity-related metabolic diseases. This review aims to summarize several adipokines discovered recently that have promising functions in obesity and T2DM. Among them, the levels of FSTL1, WISP1 and Asprosin in subjects with obesity or diabetes are commonly higher than in normal controls, suggesting that they may be pathogenic. Inversely, SFRP5, Metrnl, NRG4 and FAM19A5 may serve as the protective factors.
摘要
肥胖被定义为脂肪组织异常或过度积累，这与各种合并症风险增加密切相关，尤其是2型糖尿病（T2DM）。脂肪组织是一种复杂的结构，不仅负责储存脂肪，还能释放脂肪因子，这些脂肪因子可能在发病机制中发挥作用，并有可能发展成为肥胖相关代谢疾病诊断、治疗和预后的生物标志物。本综述旨在总结最近发现的几种在肥胖和T2DM中具有潜在功能的脂肪因子。其中，肥胖或糖尿病患者体内的FSTL1、WISP1和Asprosin水平通常高于正常对照组，这表明它们可能具有致病性。相反，SFRP5、Metrnl、NRG4和FAM19A5可能是保护因子。
相似文献
1
New Discovered Adipokines Associated with the Pathogenesis of Obesity and Type 2 Diabetes.
Diabetes Metab Syndr Obes. 2022 Aug 7;15:2381-2389. doi: 10.2147/DMSO.S376163. eCollection 2022.
2
Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases.
Front Physiol. 2020 Oct 30;11:578966. doi: 10.3389/fphys.2020.578966. eCollection 2020.
3
Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
Mol Metab. 2017 Jun 21;6(8):863-872. doi: 10.1016/j.molmet.2017.03.016. eCollection 2017 Aug.
4
Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence.
Cytokine Growth Factor Rev. 2021 Aug;60:120-132. doi: 10.1016/j.cytogfr.2021.05.002. Epub 2021 May 28.
5
Adipose Tissue-Derived Signatures for Obesity and Type 2 Diabetes: Adipokines, Batokines and MicroRNAs.
J Clin Med. 2019 Jun 14;8(6):854. doi: 10.3390/jcm8060854.
6
Low serum levels of meteorin-like/subfatin: an indicator of diabetes mellitus and insulin resistance?
Endokrynol Pol. 2020;71(5):397-403. doi: 10.5603/EP.a2020.0038. Epub 2020 Jun 29.
7
Adipokines, Hepatokines and Myokines: Focus on Their Role and Molecular Mechanisms in Adipose Tissue Inflammation.
Front Endocrinol (Lausanne). 2022 Jul 14;13:873699. doi: 10.3389/fendo.2022.873699. eCollection 2022.
8
Research update on the association between SFRP5, an anti-inflammatory adipokine, with obesity, type 2 diabetes mellitus and coronary heart disease.
J Cell Mol Med. 2020 Mar;24(5):2730-2735. doi: 10.1111/jcmm.15023. Epub 2020 Jan 31.
9
Circulating levels of asprosin and its association with insulin resistance and renal function in patients with type 2 diabetes mellitus and diabetic nephropathy.
Mol Biol Rep. 2021 Jul;48(7):5443-5450. doi: 10.1007/s11033-021-06551-2. Epub 2021 Jul 25.
10
Potential emerging roles of the novel adipokines adipolin/CTRP12 and meteorin-like/METRNL in obesity-osteoarthritis interplay.
Cytokine. 2021 Feb;138:155368. doi: 10.1016/j.cyto.2020.155368. Epub 2020 Nov 25.
引用本文的文献
1
High intensity interval training attenuate insulin resistance in diabetic rats accompanied by improvements in liver metabolism and spexin signaling.
Sci Rep. 2025 Aug 21;15(1):30682. doi: 10.1038/s41598-025-15432-8.
2
Distachionate and Its Nanocomposites Modulate Oxidative Stress, Inflammation, and Diabetes-Related Genes in High-Fructose/Streptozotocin Model.
ACS Omega. 2025 Jul 23;10(30):33353-33370. doi: 10.1021/acsomega.5c03465. eCollection 2025 Aug 5.
3
Serum Wnt1-Inducible signalling pathway Protein-1 levels are associated with cerebral infarction in patients with type 2 diabetes mellitus.
J Endocrinol Invest. 2025 Jul 28. doi: 10.1007/s40618-025-02662-w.
4
Unraveling the complexities of diet induced obesity and glucolipid dysfunction in metabolic syndrome.
Diabetol Metab Syndr. 2025 Jul 22;17(1):292. doi: 10.1186/s13098-025-01837-y.
5
Circulating CCN6/WISP3 in type 2 diabetes mellitus patients and its correlation with insulin resistance and inflammation: statistical and machine learning analyses.
BMC Med Inform Decis Mak. 2025 Mar 6;25(1):114. doi: 10.1186/s12911-025-02957-1.
6
Relationship of asprosin and diabetes: a meta-analysis.
BMC Endocr Disord. 2025 Jan 23;25(1):15. doi: 10.1186/s12902-025-01843-1.
7
Association of serum Metrnl levels and high-density lipoprotein cholesterol in patients with type 2 diabetes mellitus: a cross-sectional study.
PeerJ. 2024 Oct 14;12:e18264. doi: 10.7717/peerj.18264. eCollection 2024.
8
The effect of hydrophilic statins on adiponectin, leptin, visfatin, and vaspin levels in streptozocin-induced diabetic rats.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):3977-3984. doi: 10.1007/s00210-024-03517-6. Epub 2024 Oct 9.
9
Circulating Myokines as Novel Biomarkers for Cardiovascular Diseases.
Rev Cardiovasc Med. 2024 Feb 5;25(2):56. doi: 10.31083/j.rcm2502056. eCollection 2024 Feb.
10
NAMPT, IL-6, and vaspin gene expressions and serum protein levels in type 2 diabetes mellitus and related complication.
Turk J Biol. 2024 Apr 3;48(2):133-141. doi: 10.55730/1300-0152.2688. eCollection 2024.
本文引用的文献
1
Follistatin-Like 1 and Family with Sequence Similarity to 19 Member A5 Levels Are Decreased in Obese Children and Associated with Glucose Metabolism.
Ann Nutr Metab. 2022;78(4):213-221. doi: 10.1159/000524624. Epub 2022 Apr 20.
2
Effect of metformin as an add-on therapy on neuregulin-4 levels and vascular-related complications in adolescents with type 1 diabetes: A randomized controlled trial.
Diabetes Res Clin Pract. 2022 Apr;186:109857. doi: 10.1016/j.diabres.2022.109857. Epub 2022 Mar 26.
3
Differential Effects of Exercise Programs on Neuregulin 4, Body Composition and Cardiometabolic Risk Factors in Men With Obesity.
Front Physiol. 2022 Feb 7;12:797574. doi: 10.3389/fphys.2021.797574. eCollection 2021.
4
Combined training increases thermogenic fat activity in patients with overweight and type 2 diabetes.
Int J Obes (Lond). 2022 Jun;46(6):1145-1154. doi: 10.1038/s41366-022-01086-3. Epub 2022 Feb 16.
5
Meal-Related Asprosin Serum Levels Are Affected by Insulin Resistance and Impaired Fasting Glucose in Children With Obesity.
Front Endocrinol (Lausanne). 2022 Jan 6;12:805700. doi: 10.3389/fendo.2021.805700. eCollection 2021.
6
Ups and downs: The PPARγ/p-PPARγ seesaw of follistatin-like 1 and integrin receptor signaling in adipogenesis.
Mol Metab. 2022 Jan;55:101400. doi: 10.1016/j.molmet.2021.101400. Epub 2021 Nov 20.
7
Association Between Factors Involved in Bone Remodeling (Osteoactivin and OPG) With Plasma Levels of Irisin and Meteorin-Like Protein in People With T2D and Obesity.
Front Endocrinol (Lausanne). 2021 Oct 29;12:752892. doi: 10.3389/fendo.2021.752892. eCollection 2021.
8
Meteorin-Like Protein (Metrnl) in Obesity, during Weight Loss and in Adipocyte Differentiation.
J Clin Med. 2021 Sep 23;10(19):4338. doi: 10.3390/jcm10194338.
9
CYP1A2 polymorphisms modify the association of habitual coffee consumption with appetite, macronutrient intake, and body mass index: results from an observational cohort and a cross-over randomized study.
Int J Obes (Lond). 2022 Jan;46(1):162-168. doi: 10.1038/s41366-021-00972-6. Epub 2021 Sep 25.
10
Nordic Walking at Maximal Fat Oxidation Intensity Decreases Circulating Asprosin and Visceral Obesity in Women With Metabolic Disorders.
Front Physiol. 2021 Sep 3;12:726783. doi: 10.3389/fphys.2021.726783. eCollection 2021.
Zotero 插件